Cilostazol as an add-on therapy for patients with Alzheimer’s disease in Taiwan: a case control study

BACKGROUND: Combination therapy using acetylcholinesterase inhibitors (AChEIs) and cilostazol is of unknown efficacy for patients with Alzheimer’s disease (AD). METHODS: We explored the therapeutic responses by using a case–control study, which was conducted in Taiwan. We enrolled 30 participants wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Shu-Yu, Chen, Chun-Hung, Chien, Chen-Yu, Yang, Yuan-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324327/
https://www.ncbi.nlm.nih.gov/pubmed/28231822
http://dx.doi.org/10.1186/s12883-017-0800-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324327/
https://www.ncbi.nlm.nih.gov/pubmed/28231822
http://dx.doi.org/10.1186/s12883-017-0800-y

Ejemplares similares